Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc van Bilsen

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Circulation|June 15, 2017
Inhibition of MicroRNA-146a and Overexpression of Its Target Dihydrolipoyl Succinyltransferase Protect Against Pressure Overload-Induced Cardiac Hypertrophy and DysfunctionWard A Heggermont, Anna-Pia Papageorgiou, Annelies Quaegebeur, et al.
European Heart Journal|January 30, 2018
Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmiasJob A J Verdonschot, Mark R Hazebroek, Kasper W J Derks, et al.
European Journal of Heart Failure|January 27, 2009
Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of CardiologyStephane Heymans, Emilio Hirsch, Stefan D Anker, et al.
Cardiovascular Research|October 17, 2013
Melusin protects from cardiac rupture and improves functional remodelling after myocardial infarctionBernhard Unsöld, Axel Kaul, Mauro Sbroggiò, et al.
Cardiovascular Research|February 13, 2018
Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffeningOana Sorop, Ilkka Heinonen, Matthijs van Kranenburg, et al.
Circulation|August 20, 2013
Macrophage microRNA-155 promotes cardiac hypertrophy and failureStephane Heymans, Maarten F Corsten, Wouter Verhesen, et al.
European Journal of Heart Failure|September 27, 2017
The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of CardiologyMarc van Bilsen, Hitesh C Patel, Johann Bauersachs, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Circulation|June 15, 2017
Inhibition of MicroRNA-146a and Overexpression of Its Target Dihydrolipoyl Succinyltransferase Protect Against Pressure Overload-Induced Cardiac Hypertrophy and DysfunctionWard A Heggermont, Anna-Pia Papageorgiou, Annelies Quaegebeur, et al.
European Heart Journal|January 30, 2018
Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmiasJob A J Verdonschot, Mark R Hazebroek, Kasper W J Derks, et al.
European Journal of Heart Failure|January 27, 2009
Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of CardiologyStephane Heymans, Emilio Hirsch, Stefan D Anker, et al.
Cardiovascular Research|October 17, 2013
Melusin protects from cardiac rupture and improves functional remodelling after myocardial infarctionBernhard Unsöld, Axel Kaul, Mauro Sbroggiò, et al.
Cardiovascular Research|February 13, 2018
Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffeningOana Sorop, Ilkka Heinonen, Matthijs van Kranenburg, et al.
Circulation|August 20, 2013
Macrophage microRNA-155 promotes cardiac hypertrophy and failureStephane Heymans, Maarten F Corsten, Wouter Verhesen, et al.
European Journal of Heart Failure|September 27, 2017
The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of CardiologyMarc van Bilsen, Hitesh C Patel, Johann Bauersachs, et al.
Pageof 7